NCT03353480View on ClinicalTrials.gov

Bioequivalence (BE) Study Comparing Azithromycin 250 mg Tablet Manufactured in China and in the United States

PHASE1CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

December 20, 2017

Primary Completion Date

January 29, 2018

Study Completion Date

February 26, 2018

Conditions
Bioequivalence
Interventions
DRUG

Azithromycin Tablet manufactured in China

250 mg Azithromycin Tablet manufactured in China

DRUG

Azithromycin Tablet manufactured in US

250 mg Azithromycin Tablet manufactured in US

Trial Locations (1)

130021

The First Hospital of Jilin University/Phase I Clinical Trials Unit, Changchun

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY